Product catalog
contact us

    KCI BioTech (Suzhou) Inc.
    Tel:0512-69998806
    Ministry of Commerce:0512-69998806-8012
    BD:
    East and South China:Ms. Gu 15378638068
    North China, East China:Mr. Han 18914988667
    Central and Western regions: Ms. Xiang 15828112963
    Project Management Department:0512-69998806-8022
    Tumor business:0512-69998806-8058
    Non tumor business:0512-69998806-8026
    Pathogenic microorganism business:0512-69998806-8037
    Integrated Service Platform:0512-69998806-8022
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

Key Model for Drug Development of Rheumatoid Arthritis

  Rheumatoid arthritis (RA) is an autoimmune disease that is pathologically based on synovitis and may eventually lead to joint deformities. Although there is no complete cure for the disease for the time being, early disease control and maintenance therapy can effectively slow down disease progression and improve patients' quality of life.
  We have established a stable model of rheumatoid arthritis, which is suitable for the study of preclinical rheumatoid arthritis drugs and the evaluation of new drugs.
  If you have a project need and experience more of our professional services, please contact us.

Our services

Model classification

Model Name

Animal species

Rheumatoid arthritis

Model of type II collagen-induced rheumatoid arthritis

Mice,rats

Adjuvant-induced rheumatoid arthritis model

rats

Model of rheumatoid arthritis induced by yeast zymosan A (ZIA)

Mice

Non-human primate model of spontaneous rheumatoid arthritis

non-human primates


Case sharing

Rat CIA model

Rat AIA model



Previous:Nothing
Next:Inflammatory bowel disease